ESC Premium Access

Mortality and atrial fibrillation in the FIACA study: evidence of a differential effect according to the diagnosis of hospital admission.

Congress Presentation

About the speaker

Doctor Daniel Fernandez-Berges

Extremadura Health System. Don Benito-Villanueva Hospital, Villanueva de la Serena (Spain)
0 follower

10 more presentations in this session

Cancer and risk of atrial fibrillation: a systematic review and meta-analysis.

Speaker: Doctor T. Liu (Tianjin, CN)

Thumbnail

Multimorbidity and comorbidity in atrial fibrillation and effects on survival: findings from UK biobank cohort

Speaker: Professor D. Connelly (Glasgow, GB)

Thumbnail

Patients with cancer and atrial fibrillation treated with NOACs: data from a prospective cohort

Speaker: Doctor M. Vedovati (Perugia, IT)

Thumbnail

Comorbid malignancy as an independent predictor of in-hospital mortality in patients with atrial fibrillation.

Speaker: Doctor K. Voudris (Chicago, US)

Thumbnail

Increased bleeding risk in cancer patients with atrial fibrillation. Can we identify risk predictors?

Speaker: Doctor A. Pardo Sanz (Madrid, ES)

Thumbnail

Access the full session

Poster session 5 - Comorbidities and mortalities

Speakers: Doctor D. Fernandez-Berges, Doctor T. Liu, Professor D. Connelly, Doctor M. Vedovati, Doctor K. Voudris...
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb